ALX-0600

Known as: ALX 0600 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Neonatal short bowel syndrome following massive gut resection is associated with malabsorption of nutrients. The intestinotrophic… (More)
Is this relevant?
Review
2008
Review
2008
BACKGROUND Malabsorption of nutrients, fluids and electrolytes is a key finding in patients with short bowel syndrome. If not… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND AND AIMS Glucagon-like peptide 2 (GLP-2) may improve intestinal absorption in short bowel syndrome (SBS) patients with… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Review
2001
Review
2001
NPS Allelix (formerly Allelix Biopharmaceuticals) is developing the glucagon-like peptide 2 (GLP-2) analog ALX-0600 for the… (More)
Is this relevant?
2001
2001
BACKGROUND Acute pancreatitis (AP) initiates a generalized inflammatory response that increases intestinal permeability and… (More)
Is this relevant?
2001
2001
 
Is this relevant?
2000
2000
BACKGROUND Glucagon-like peptide 2 (GLP-2) is a recently identified intestinal epithelium-specific growth factor that has been… (More)
Is this relevant?
2000
2000
PURPOSE Treatment of short bowel syndrome (SBS) can be difficult; this study examines the effect of parental administration of… (More)
Is this relevant?